Brought to you by 
SuppreMol raises €15.7mm through Series B round
25 Jul 2008
Executive Summary
MIG AG and BioMedInvest AG co-led a €15.7mm ($25mm) Series B round for SuppreMol GMBH (autoimmune disease therapeutics). Other buyers included Santo Holding and existing investors Zetacube, KFW Mittelstandsbank, Bayern Capital, and Max-Planck-Gesellschaft.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SuppreMol raises €15.7mm through Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice